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Abstract
 
The effector cytokine interferon 
 
 
 
 (IFN-
 
 
 
) may play a role in T cell homeostasis. We have ex-
amined the requirement for IFN-
 
 
 
 in one mechanism that regulates T cell expansion and sur-
vival, activation-induced cell death (AICD). CD4
 
 
 
 T cells lacking IFN-
 
 
 
 or the Stat1 tran-
scription factor are resistant to AICD. IFN-
 
 
 
 is required for the production of caspases, and
retrovirus-mediated expression of caspase-8 restores the sensitivity of Stat1-deficient T cells to
AICD. In vitro, IFN-
 
 
 
 limits the expansion of T cells that are stimulated through their antigen
receptors. Thus, IFN-
 
 
 
 may function to control the expansion and persistence of T cells by
promoting caspase-8–dependent apoptosis.
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Introduction
 
IFN-
 
  
 
is the principal effector cytokine of cell-mediated
immunity. Recent studies suggest that IFN-
 
 
 
 also plays a
previously unsuspected role in the homeostatic control of
T cells. If mice lacking IFN-
 
 
 
 are infected with mycobac-
teria, there is a progressive expansion of T cells that is not
attributable to increased numbers or persistence of bacteria
(1). Similarly, after 
 
Listeria
 
 infection, the frequency of mi-
crobe-specific CD8
 
 
 
 T cells is greater in IFN-
 
 
 
 
 
/
 
 
 
 than in
wild-type mice, and the decline of T cells is delayed (2).
 
This regulatory role of IFN-
 
 
 
 may also be relevant to
immune responses to antigens other than microbial anti-
gens. For instance, IFN-
 
 
 
 
 
/
 
 
 
 mice and normal mice
treated with anti–IFN-
 
 
 
 antibody show paradoxically more
severe encephalitis after immunization with myelin pro-
teins than do normal mice (3–5). Despite these studies
suggesting an obligatory role of IFN-
 
 
 
 in T cell homeosta-
sis, the mechanisms by which this cytokine regulates T cell
expansion and survival are unknown.
Apoptotic death of lymphocytes is a major homeostatic
mechanism in the immune system (6). One pathway of
apoptosis, called activation-induced cell death (AICD), is
induced by antigen stimulation under particular conditions.
Repeated stimulation by antigen results in engagement of
death receptors and activation of caspase-8 (7–9). In CD4
 
 
 
T cells, the major death receptor responsible for triggering
this pathway of AICD is Fas (CD95; reference 10). Fas-
mediated AICD is known to play an essential role in the
deletion of self-reactive lymphocytes, and may also be in-
volved in the deletion of T cells chronically exposed to for-
eign antigens, such as persistent microbes. We and others
have previously shown that in vitro, death of previously ac-
tivated T cells induced by restimulation with anti-CD3 is
largely dependent upon the ligation of Fas (10–12). A sec-
ond pathway of AICD is induced by T cell stimulation in
the absence of innate immunity or costimulation. This type
of stimulation results in activation of pro-apoptotic mem-
bers of the bcl-2 family, such as Bim, in the absence of an-
tiapoptotic members, and T cell death without engagement
of death receptors (13).
 
In previous studies of the regulation of AICD, we had
noticed that differentiated Th2 cells were less sensitive to
this death pathway than were Th1 cells. We hypothe-
sized that the basis of this death resistance may be the ab-
 
sence of IFN-
 
 
 
 production in Th2 cells. Such a function
of IFN-
 
 
 
 in potentiating AICD may also account for the
role of this cytokine in T cell homeostasis. In this paper,
we show that IFN-
 
 
 
 is indeed required for activation-
induced death of T cells. Furthermore, IFN-
 
 
 
 functions
by stimulating the expression of caspases downstream of
the Fas death receptor, through the transcriptional activ-
ity of Stat1.
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IFN-
 
 
 
 in Apoptosis
 
Materials and Methods
 
Mice.
 
3A9/
 
 
 
 and 3A9/IL-2
 
 
 
/
 
 
 
 TCR transgenic mice have
been described previously (14). IFN-
 
 
 
 
 
/
 
 
 
 mice, on a C57BL/6
background, and normal C57BL/6 mice were obtained from the
The Jackson Laboratory. Stat1
 
 
 
/
 
 
 
 mice, on a 129sv background,
were obtained from Dr. R.D. Schreiber (Washington University,
St. Louis, MO) through Taconic Farms. All of the mice used in
these experiments were 3–4-wk-old and were maintained in ac-
cordance with the guidelines of the Committee on Animals of the
University of California San Francisco and those of the institute of
Laboratory Animal Resources, National Research Council.
 
T Cell Purification and In Vitro Activation.
 
Naive CD4
 
 
 
 T cells
were isolated from pooled spleen and lymph nodes, as described
previously (14). Briefly, cell suspensions were incubated with anti-
CD4 coated magnetic beads (Dynal) for 45 min, at 4
 
 
 
C. The ad-
herent cells were washed twice and incubated for 45 min with the
Dynal Detach antibody. For in vitro activation, 2 
 
 
 
 10
 
5
 
 naive
CD4
 
 
 
 T cells were cultured with 2 
 
 
 
 10
 
6
 
 mitomycin C (Sigma-
Aldrich) treated H-2
 
k
 
 spleen cells in the presence of 1 
 
 
 
g/ml of
HEL(46–61) peptide. Some cultures were supplemented with IL-2
at 50 U/ml, and IFN-
 
 
 
 at 10 U/ml. The activation cultures were
performed in RPMI 1640 with 10% heat inactivated fetal calf se-
rum (GIBCO BRL), 
 
l
 
-glutamine, penicillin, streptomycin, non-
essential amino acids, sodium pyruvate, and 2-
 
 
 
 mercaptoethanol
(all from GIBCO BRL). To activate T cells without APCs, 10
 
6
 
CD4
 
 
 
 T cells were cultured with 1 
 
 
 
g/ml of soluble anti-CD3
antibody (2C11), and 10 
 
 
 
g/ml of anti-CD28 antibody (37N1;
both from BD Biosciences), with or without added cytokines
(R&D Systems). The in vitro primed T cells did not produce de-
tectable IL-4 or IL-5 upon restimulation (unpublished data).
TCR-induced proliferation was assayed by incubating 10
 
6
 
CFSE-stained, naive CD4
 
 
 
 T cells with 1 
 
 
 
g/ml soluble anti-
CD3 (clone 2C11; BD Biosciences) and 10 
 
 
 
g/ml soluble anti-
CD28 (clone 37N1; BD Biosciences), for 3 d, and determining
cell division number by flow cytometry. For the secondary pro-
liferative responses to TCR stimulation, 5 
 
 
 
 10
 
3
 
 previously acti-
vated cells were incubated with the indicated amounts of soluble
anti-CD3 antibody (see Fig. 4), and incubated in complete media
for 48 h. The activated cells were pulsed with 1 
 
 
 
Ci of [H
 
3
 
]thy-
midine for 12 h. The level of DNA replication was determined
by quantifying the number of counts per minute using a Perkin-
Elmer 
 
 
 
-counter. All values were derived from the means of trip-
licate wells, and error bars represent the standard deviations.
In vitro–activated T cells obtained from the various mutant mice
used in the present studies were stained for surface expression of Fas
and FasL as described previously (14). Activated T cells were reacti-
vated by incubation for 12 h in anti-CD3 coated plates. These cells
were collected and washed and incubated with PE-conjugated anti-
Fas antibodies (Jo-2 clone; BD Biosciences), or with an anti-FasL
Figure 1. IL-2 and IFN-  independently regulate AICD. CD4  T cells were purified from pooled spleen and lymph node suspensions obtained from
C57BL/6 (WT), IFN-  / , or Stat1 /  mice (A–C), or from 3A9/  (wild-type) and 3A9/IL-2 /  mice (D–F). These cells were activated in vitro with
anti-CD3 and anti-CD28, with the following cytokines added to the cultures: none (A and D), IL-2 (50 U/ml; B and E), or IFN-  (10 U/ml; C and F).
Activated cells were collected 3 d later, and incubated on anti-CD3 coated plates in the presence of IL-2. Apoptosis was determined by Propidium Iodide
staining. The same cells were analyzed for the expression of FasL (G) and Fas (H) by staining and flow cytometry. The filled histograms in G represent
resting cells and the empty histograms represent activated T cells. The filled histograms in H represent cells that were stained with an isotype-matched
control antibody and the empty histograms represent cells that were stained with anti-Fas. 
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monoclonal antibody (H11; a gift form Dr. Jürg Tschopp, Univer-
sity of Lausanne, Lausanne, Switzerland). These cells were incu-
bated with a PE-conjugated secondary antibody (BD Biosciences).
 
Assays for Apoptosis.
 
T cells were activated as described above
with the indicated cytokine added to the culture. After 3 d in cul-
ture, viable cells were isolated on a ficoll gradient. 10
 
6
 
 activated T
cells were then cultured in duplicate wells coated with 0–1 
 
 
 
g/ml
anti-CD3 antibody, in the presence of IL-2 (50 U/ml). Controls
in these experiments consisted of 10
 
6
 
 cells cultured in IL-2 only.
After 20 h, cells were collected, washed twice in PBS supple-
mented with 0.1% 
 
d
 
-glucose, and fixed in 70% ethanol overnight
at 4
 
 
 
C. The cells were spun and resuspended in 0.5 ml of a solu-
tion of 50 
 
 
 
g/ml Propidium Iodide containing 1 
 
 
 
g/ml RNaseA,
diluted in PBS plus 0.1% 
 
d
 
-glucose. Percentage apoptotic cells
were determined by flow cytometry using a Becton Dickinson
FACSCalibur™, by gating on the subdiploid population.
 
RNase Protection Assays.
 
RNA was obtained from 10
 
7
 
 acti-
vated T cells using Trizol reagent (GIBCO BRL), following
manufacturer’s specifications. The RNase protection was per-
formed using 5 
 
 
 
g of RNA with the Riboquant multi-probe
RNase protection assay system (BD Biosciences), following the
manufacturer’s specifications. In brief, RNA was hybridized
overnight with the in vitro translated 
 
32
 
P-labeled probe (mAPO-1
kit; BD Biosciences). After hybridization, samples were treated
with RNase A and proteinase K, phenol/chloroform extracted,
and ethanol precipitated. The protected fragments were resolved
by electrophoresis on a 5% acrylamide/urea gel, and exposed on
XAR film (Eastman Kodak Co.) as well as on a PhosphorImager
cassette (Molecular Devices). The intensity of each band was de-
termined using ImageQuant software, and normalized to an aver-
age of both control probes (GAPDH and L32).
 
Retroviral Infections.
 
The cDNA for human caspase-8 was
cloned into a bicistronic IRES-GFP containing vector which is a
 
variant of pMIG (15) that contains a posttranscriptional regula-
tory element from the woodchuck hepatitis virus (16) and is
called pMIG-w. This virus shows 5 to 10-fold greater higher ex-
pression of genes in primary lymphocytes (unpublished data).
Retroviral infection of primary murine CD4
 
 
 
 T cells were per-
formed as described previously. Briefly, CD4
 
 
 
 T cells obtained
from pooled spleen and lymph nodes from Stat1
 
 
 
/
 
 
 
 mice were
activated for 3 d with anti-CD3 and anti-CD28. Retrovirus in-
fections were performed at 24 and 48 h of culture as described
(15). Under these conditions, the transfection efficiency is rou-
tinely 40–60%. The cells were assayed for apoptosis, as described
above, gating on GFP
 
 
 
 cells.
The levels of caspase-8 in retrovirus-infected cells were deter-
mined by Western blot analysis. The cells were washed in chilled
Dulbecco’s PBS (GIBCO BRL). Cells were lysed in 0.1% NP-40
containing lysis buffer, as described previously (14). Lysates were
run on a 12% SDS-PAGE. Blots were probed with an anti-Cas-
pase-8 monoclonal antibody (New England Biolabs, Inc./Cell
Signaling Technologies), followed by a rabbit anti–mouse HRP-
conjugated antibody (Santa Cruz Biotechnology, Inc.). Western
blots were developed using an ECL kit (Amersham Biosciences)
and exposed to XLS film (Eastman Kodak Co.).
 
Results and Discussion
 
IFN-
 
 
 
 Signals Are Required for AICD.
 
To assess the role
of IFN-
 
 
 
 in AICD, we analyzed CD4
 
 
 
 T cells from knock-
out mice lacking IFN-
 
 
 
 or lacking the major transcription
factor activated by the IFN receptor, Stat1. T cells activated
with anti-CD3 plus anti-CD28 antibodies were exposed to
anti-CD3 antibody, to mimic repeated antigen stimulation,
and apoptosis was assayed. We have previously shown that
Figure 2. IFN-  and Stat1 in-
crease the levels of caspase tran-
scripts. CD4  T cells were puri-
fied from pooled lymph node and
spleen suspensions obtained from
C57BL6 (WT), IFN-  / ,
Stat1 / , 3A9/ , or 3A9/IL-2 / 
mice. These cells were activated
with antibodies to CD3 and
CD28, with no added cytokine,
or with added IFN- . Activated
cells were collected after 3 d, and
mRNA for caspases was assayed
by RNase protection. The pro-
tected species were resolved on a
TBE/Urea gel, and the bands
quantified using a PhosphorIm-
ager, a representative example is
shown in A. Levels of mRNA (B
and C) were calculated by averag-
ing the two bands for the house-
keeping genes (L32 and
GAPDH), and determining the
percentage of the value for each of
the caspase probes. The data were
pooled from two independent ex-
periments. (D) The levels of
caspase-8 protein in CD4  T cells
from C57BL-6 (WT), IFN-  / ,
and Stat1 /  mice activated for 1
or 3 d with no added cytokine or
with IFN-  (10 U/ml) were de-
termined by Western blot analysis. 
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under these conditions, death of CD4  T cells is entirely de-
pendent on Fas-Fas ligand (FasL) interactions (12, 14). Mice
lacking IFN-  or Stat1 did not undergo apoptosis whereas
wild-type cells did (Fig. 1 A). The defect of the IFN-  / 
mice was corrected by adding IFN- , showing that there is
no intrinsic developmental defect in the T cells, and their re-
sistance to AICD is entirely attributable to the lack of IFN- 
production. In addition, the activated IFN-  /  T cells did
not produce IL-4 (data not shown), suggesting that these
cells did not differentiate into Th2 type cells by default. As
expected, adding IFN-  to wild-type T cells (which pro-
duce IFN-  and are not defective in AICD) had no detect-
able effect. The finding that Stat1 /  T cells show the same
defect as IFN-  /  cells indicates that the role of this cyto-
kine in AICD is dependent on the Stat1 transcription factor.
As we and others have shown previously (14, 17), IL-2 is
also required for AICD of CD4  T cells (Fig. 1 B; note that
to examine IL-2 /  T cells, we used mice expressing a TCR
transgene, 3A9, crossed with IL-2 knockouts, because the
transgenic antigen receptor retards the severe autoimmune
disease of these knockouts, presumably by limiting the rep-
ertoire of autoreactive T cells). Addition of IL-2 restored the
sensitivity of IL-2 /  T cells to AICD, and addition of IFN- 
made IFN-  /  T cells sensitive (Fig. 1). However, the ef-
fect of each cytokine was specific, suggesting that IFN-  and
IL-2 are independently required for AICD and may act by
distinct mechanisms.
To ask if IFN-  is required for the expression of Fas or
FasL, activated T cells were stained with specific antibodies
and analyzed by flow cytometry. As shown in Fig. 1, G and
H, IFN-   /  and Stat-1 /  T cells expressed normal lev-
els of FasL and Fas. Furthermore, these T cells were also
resistant to apoptosis induced by antibody-mediated cross-
linking of Fas (data not shown). Taken together, these re-
Figure 3. Retrovirally transduced caspase-8 is able
to correct the AICD defect observed in Stat1     T
cells. (A) CD4  T cells were purified from pooled
spleen and lymph node suspensions obtained from ei-
ther C57BL-6 (wt), or Stat1 /  mice. These cells were
activated and infected in vitro with bicistronic retrovi-
ral vectors encoding caspase-8 (two different clones, 8–7
and 8–15) or empty vector (pMIG). The infected cells
were then incubated on anti-CD3 coated plates for 20 h
to induce AICD, and apoptosis was assayed in GFP 
cells by flow cytometry. The data presented here were
obtained from averaging the results of triplicate wells,
from one experiment representative of three. (B) The
specificity of the requirement for caspase-8 was deter-
mined by retrovirally transducing CD4  T cells from
either C57BL/6 (wt), or Stat1 /  mice with viruses
encoding caspase-3 (Casp3), caspase-8 (Casp8), or
caspase-9 (Casp9), and processed as in A. (C) The lev-
els of caspase-8 expression in retrovirus-infected acti-
vated C57BL/6 (WT) and Stat1 /  cells were verified
by Western blot analysis.1003 Refaeli et al. Brief Definitive Report
sults suggest that the defect in this pathway of AICD seen
in IFN-   /  and Stat-1 /  T cells must be downstream of
the expression of the death receptor and its ligand.
IFN-  Is Required for Caspase Production. The sensitiv-
ity of cells to Fas-mediated apoptosis is controlled by the
formation of the death-inducing signaling complex and
the subsequent activation of caspases (7, 9). Fas is cross-
linked by its ligand, resulting in the binding of an adaptor
protein, which then recruits and activates pro-caspase-8.
The endogenous inhibitor of apoptosis, c-FLIP, blocks the
binding of pro-caspase-8 and thus prevents the propaga-
tion of the apoptotic signal. In this sequence, FasL is
proapoptotic and FLIP is antiapoptotic. We have previ-
ously shown that IL-2 renders T cells sensitive to AICD by
increasing FasL expression and inhibiting FLIP expression
(14). Similar experiments with T cells lacking IFN-  or
Stat1 showed that IFN-  is not required for enhancing the
expression of FasL or inhibiting the transcription of FLIP
(data not shown). We, therefore, postulated that the action
of IFN-  may be distal to formation of the death-inducing
signaling complex, perhaps in the expression of caspases.
To test this, we first assayed levels of RNA for several cas-
pases in activated T cells from IFN-  /  and Stat1 / 
mice. In the absence of IFN-  signals, T cells contained
virtually no RNA for the initiator caspase that is down-
stream of death receptors, caspase-8, and reduced RNA
for effector caspases such as caspase-3 and caspase-6 (Fig. 2,
A and B). Furthermore, levels of caspase-8 RNA were re-
stored by the addition of IFN-  in IFN-  /  T cells but
not, as expected, in Stat1 /  T cells (Fig. 2 C). The same
results were seen when levels of caspase-8 protein were as-
sayed by Western blotting (Fig. 2 D). Note that in wild-
type T cells, the addition of IFN-  does not increase the
level of caspase-8, presumably because the cells make IFN- 
at optimal levels. As this caspase is the initiator caspase that
is activated by death receptors, these results indicate that
IFN-  and Stat1 are uniquely involved in apoptosis medi-
ated by death receptor triggering. Also, T cells express lit-
tle or no caspase-1 mRNA, which is not surprising, as the
function of this enzyme is to cleave the precursor form of
IL-1 . In fibroblasts, caspase-1 production may also be
stimulated by cytokines (18).
Figure 4. IFN-  regulates the number of cells follow-
ing antigenic stimulation by affecting apoptosis but not
cell division and proliferation. CD4  T cells were puri-
fied from pooled spleen and lymph node suspensions
obtained from either C57BL/6 (wild type), IFN-  / 
mice, or Stat-1 /  mice. (A) The cells were cultured
with anti-CD3 and anti-CD28 antibodies for 4 d,
rested in medium plus cytokines, as indicated, restimu-
lated with soluble anti-CD3 antibodies at the indicated
concentrations. These cultures were pulsed with
[H3]thymidine for 12 h, 2 d after initial activation. (B)
Freshly isolated cells were labeled with CFSE, activated
with antibodies to CD3 and CD28, in the presence of
exogenously added cytokines, as indicated. The acti-
vated T cells were analyzed by flow cytometry four
days after activation.1004 IFN-  in Apoptosis
If the principal reason why IFN-  /  or Stat1 /  T cells
are insensitive to AICD is a deficiency of caspase-8, en-
forced expression of this enzyme should restore the sensi-
tivity of the T cells to Fas-mediated apoptosis. To test this
possibility, we introduced three different caspases into
wild-type and Stat1 /  T cells using a bicistronic retroviral
vector in which GFP serves as a marker for viral infection,
and assayed AICD in GFP  cells. As shown in Fig. 3, ex-
pression of caspase-8, but not caspase- 3 or caspase-9, made
Stat1 /  T cells sensitive to AICD. Furthermore, upon re-
peated activation, we detected two bands for caspase-8 by
Western blotting, consistent with cleavage of the enzyme
as a result of Fas-signaling (data not shown).
Role of IFN-  in T Cell Expansion. If IFN-  enhances
AICD in T cells, then it should reduce the accumulation of
T cells that are repeatedly stimulated by their antigen re-
ceptors, which is the situation most likely to trigger AICD.
To test this possibility, we stimulated wild-type, IFN-  / 
or Stat1 /  T cells with anti-CD3 plus anti-CD28 anti-
bodies, and assayed the incorporation of [3H]thymidine as a
measure of cell survival and proliferation. T cells lacking
IFN-  or Stat1 showed significantly greater [3H]thymidine
incorporation than wild-type cells, and the response of the
IFN-  /  cells was reduced to wild-type levels by culture
in the presence of the cytokine (Fig. 4 A). To more directly
determine if these differences were attributable to cycling,
we labeled cells with CFSE and measured dilution of the
dye as an assay for cycling. As shown in Fig. 4 B, there was
no difference in the cycling of normal, IFN-  /  or
Stat1 /  cells, and cycling was not inhibited by the cyto-
kine. Therefore, IFN-  reduces T cell expansion, presum-
ably by reducing survival and not by inhibiting cell cycling.
This is the likely explanation for the finding that IFN-  in-
hibits T cell expansion (19), which was previously attrib-
uted to an antiproliferative effect.
The proapoptotic activity of IFN-  that we describe
supports an emerging idea that this cytokine may function
not only as an effector of cell-mediated immunity but also
as a regulator of T cell survival (1–5). It is possible that
IFN-  production by differentiated Th1 cells contributes
to the elimination of these cells, especially in situations of
prolonged antigen stimulation, such as chronic infections
and responses to self-antigens. This mechanism of T cell
elimination will be important for preventing damage to
host tissues during infections, because Th1 cells are pro-
inflammatory and potentially injurious. The finding that
two cytokines, IL-2 and IFN- , are both required for Fas-
mediated apoptosis raises the possibility that these cytokines
may function in homeostasis at different stages of immune
responses. IL-2 may act early, even on T cells that have not
differentiated into Th1 effectors, whereas IFN-  may act
only on differentiated Th1 cells. T cells that differentiate
along the Th1 pathway may transiently reduce their ex-
pression of IFN-  receptors (20, 21) and become resistant
to the cytokine. It is possible that IFN-  receptors are re-
expressed at different stages of Th1 responses, allowing re-
sponses to be terminated by IFN- . It is also interesting
that mutations in IL-2 or the   or   chain of the IL-2 re-
ceptor result in autoimmunity (22), but IFN-  /  mice do
not develop autoimmune disease. We do not know if this
difference is because of the stage or type of T cell response
that is regulated by these cytokines, or because IL-2 has
functions important for maintaining self-tolerance in addi-
tion to sensitizing T cells for AICD.
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